Two drugs are better than one to start T2DM therapy,Nature Reviews Endocrinology

当前位置： X-MOL 学术 › Nat. Rev. Endocrinol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Two drugs are better than one to start T2DM therapy
Nature Reviews Endocrinology ( IF 31.0 ) Pub Date : 2019-11-08 , DOI: 10.1038/s41574-019-0294-3
Francesco Prattichizzo ₁ , Lucia La Sala ₁ , Antonio Ceriello ₁

Affiliation

Early and intensive glycaemic control protects patients with type 2 diabetes mellitus (T2DM) from the development of late cardiovascular complications. The authors of the VERIFY trial now show that a more durable attainment of HbA1c <7% is observed by adding vildagliptin to metformin as starting therapy in newly diagnosed patients with T2DM.

中文翻译：